跳至主要内容
临床试验/NL-OMON20322
NL-OMON20322已完成不适用

A Multicenter Phase III Randomised Trial comparing Total Mesorectal Excision with Pre-operative Radiotherapy with or without Post-operative Oral Capecitabine in the Treatment of Operable Primary Rectal Cancer.

Dutch Colorectal Cancer Group0 个研究点目标入组 840 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
840

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Rectal adenocarcinoma confirmed by histological examination of the biopsy specimen, located below the level of S1/S2 on a barium enema, CT scan or MRI scan, or either located within 15 cm of the anal verge, measured during withdrawal of the flexible scope;
  • 2. Preoperative short term hypofractioned radiotherapy (5x5 Gy);

排除标准

  • 1. Evidence of macroscopic residual disease (R2);
  • 2. T1 or T2 tumour with the presence of micrometastasis without the presence of macrometastasis;

研究者

发起方
Dutch Colorectal Cancer Group

相似试验